ArticleClinical and translational medicine2022

Renaming the SARS-CoV-2 Omicron sublineages as SARS-CoV-3 is contrary to nomenclature standards based on evolutionary and serological evidence.

Zhongtian Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.